TLR4 and fatty liver disease: Previous studies showed that, in the heart, MD2 knockout reduced the direct binding of Ang II to TLR4 leading to reduced NF-κB nuclear translocation, and ultimately reduced cardiac inflammation and remodeling [12]; in the liver, inhibition of MD2 reduced inflammatory response and attenuated fatty liver disease which is not alcoholic to progress [29].